An isolation strategy for biomarkers that predict cancer relapse after 5-FU based adjuvant chemotherapy

被引：0
|
作者：
Nishizuka, Satoshi Stephen [1 ]
Ishida, Kazushige [2 ]
Uesugi, Noriyuki [1 ]
Chiba, Takehiro [1 ]
Matsuo, Teppei [1 ]
Yamada, Noriyuki [1 ]
Otsuka, Koki [1 ]
Koeda, Keisuke [1 ]
Sugai, Tamotsu [1 ]
Wakabayashi, Go [1 ]
机构：
[1] Iwate Med Univ, Sch Med, Morioka, Iwate 020, Japan
[2] NCI, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4129
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Identification of novel factors predicting non-relapse after 5-FU-based adjuvant chemotherapy for colorectal cancer
    Hirasaki, Masataka
    Mihara, Yoshiaki
    Hamaguchi, Tetsuya
    CANCER SCIENCE, 2023, 114 : 1885 - 1885
  • [12] LONG-TERM SURVIVAL FOLLOWING RELAPSE AFTER 5-FU BUT NOT CMF ADJUVANT BREAST-CANCER THERAPY
    CHLEBOWSKI, RT
    WEINER, JM
    REYNOLDS, R
    LUCE, J
    BULCAVAGE, L
    BATEMAN, JR
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 7 (01) : 23 - 29
  • [13] ANIMAL STUDIES ON THE QUESTION OF ADJUVANT 5-FU AND BCNU CHEMOTHERAPY IN GASTRIC-CANCER
    KNORR, V
    SCHMITZ, R
    CHIRURG, 1980, 51 (09): : 601 - 605
  • [14] Adjuvant chemotherapy with 5-FU or regimens including oral fluoropyrimidine for curable gastric cancer
    Mitsuru Sasako
    Gastric Cancer, 2009, 12 : 10 - 15
  • [15] Adjuvant chemotherapy with 5-FU or regimens including oral fluoropyrimidine for curable gastric cancer
    Sasako, Mitsuru
    GASTRIC CANCER, 2009, 12 : 10 - 15
  • [16] 5-Fluorouracil (5-FU) plus leucovorin versus 5-FU leucovorin plus interferon-A given as adjuvant chemotherapy in colon cancer
    Papacostas, P
    Stathopoulos, GP
    Malamos, NA
    Michailakis, E
    Rigatos, S
    Golematis, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 752 - 752
  • [17] PROLONGED SURVIVAL FOLLOWING RELAPSE AFTER 5-FU BUT NOT CMF ADJUVANT BREAST-CANCER THERAPY - RESULTS AT 9 YEARS
    CHLEBOWSKI, RT
    WEINER, JM
    REYNOLDS, R
    LUCE, J
    LANG, J
    HESTORFF, R
    GODFREY, T
    BATEMAN, JR
    BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 335 - 335
  • [18] ADJUVANT THERAPY WITH 5-FU AFTER SURGICAL RESECTION OF COLO-RECTAL CANCER
    GRAGE, T
    CORNELL, G
    STRAWITZ, J
    JONAS, K
    FRELICK, R
    METTER, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 258 - 258
  • [19] HIF-1α is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy
    Nakamura, Jun
    Kitajima, Yoshihiko
    Kai, Keita
    Hashiguchi, Kazuyoshi
    Hiraki, Masatsugu
    Noshiro, Hirokazu
    Miyazaki, Kohji
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (05) : 1158 - 1171
  • [20] Incomplete 5-FU based adjuvant chemotherapy in patients with stage III colon cancer significantly prolongs overall survival
    Hoffmann, Martin
    Ogbonnaya, Lucky
    Benecke, Claudia
    Braun, Ruediger
    Zimmermann, Markus
    Schloericke, Erik
    Keck, Tobias
    INTERNATIONAL JOURNAL OF SURGERY OPEN, 2018, 14 : 19 - 26
12345